BTW that #Phase 3 trials for these meds showed that after 68 weekly treatments the average weight loss was 5% from baseline. In the follow up phase, two thirds of that weight was regained soon after the drug was stopped. The placebo group only regained 1% back in the same period. So there is a rebound effect.
https://diabetes.medicinematters.co...ebounds-after-semaglutide-withdrawal/20384552
The trials for diabetics also used a Low Calorie Low fat diet at the same time. The trials were paid for and executed by the drug companies. the data from those trials are not available for independent analysis. No serious events were reported in any of the trials.#
Ozempic is now fully licenced for the treatment of obesity in adults
https://www.nice.org.uk/news/article/nice-recommends-new-drug-for-people-living-with-obesity
Note that this is a non diabetic use, so anyone can apply. In the USA heart patients are excluded, but no other exclusions apply.
So it is being prescribed to people who have no access to glucose measuring equipment,and would not recognise a hypo if they met one. Similarly they will be unaware of DKA. It is not yet available off scrip as OTC but that is coming. So once again we have powerful drugs being given out like sweets. But these are not soft fluffy bunny meds. I note that for non diabetics you have to have a BMI of 35 or over, but the limit for diabetic I have seen is 27.